The A2143G point mutation of clarithromycin resistance affects Helicobacter pylori eradication.
De Francesco
Vincenzo
V
Zullo
Angelo
A
Ierardi
Enzo
E
Giorgio
Floriana
F
Perna
Federico
F
Hassan
Cesare
C
Panella
Carmine
C
Vaira
Dino
D
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D017291:Clarithromycin / Q000494:pharmacology*; D004269:DNA, Bacterial / Q000032:analysis / Q000235:genetics; D024881:Drug Resistance, Bacterial / Q000235:genetics*; D016481:Helicobacter Infections / Q000188:drug therapy* / Q000382:microbiology; D016480:Helicobacter pylori / Q000187:drug effects* / Q000235:genetics; D006801:Humans; D017354:Point Mutation; D016133:Polymerase Chain Reaction / Q000379:methods; D017211:Treatment Failure; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D004269:DNA, Bacterial; D017291:Clarithromycin